<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">BENZONATATE <img border="0" src="../images/pr.gif"/></span><br/>(ben-zoe'na-tate)<br/><span class="topboxtradename">Tessalon<br/></span><b>Classifications:</b> <span class="classification">antitussive</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Nonnarcotic antitussive chemically related to tetracaine. Antitussive activity reported to be somewhat less effective than
         that of codeine. Does not inhibit respiratory center at recommended doses.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Decreases frequency and intensity of nonproductive cough.</p>
<h1><a name="uses">Uses</a></h1>
<p>Decreases frequency and intensity of nonproductive cough in acute and chronic respiratory conditions. Also used in bronchoscopy,
         thoracentesis, and other procedures when coughing must be avoided.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Safe use during pregnancy (category C) or lactation is not established.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Antitussive</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 100 mg t.i.d. prn up to 600 mg/d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>, 8 mg/kg/d in 36 divided doses<br/></i></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Ensure that soft capsules called perles are swallowed whole.</li>
<li>Store in airtight containers protected from light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Low incidence. <span class="typehead">CNS:</span> Drowsiness, sedation headache, mild dizziness. <span class="typehead">GI:</span> Constipation, nausea. <span class="typehead">Skin:</span> Rash, pruritus. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead"> Onset:</span> 1520 min. <span class="typehead">Duration:</span> 38 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Auscultate lungs anteriorly and posteriorly at scheduled intervals.</li>
<li>Observe character and frequency of coughing and volume and quality of sputum. Keep physician informed.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not chew or allow perle to dissolve in mouth; swallow whole. If perle dissolves in mouth, the mouth, tongue, and pharynx
            will be anesthetized. Also it is unpleasant to taste.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>